Quadranr Foundation Alzheimer's Research

28 November 1994

- Quadrant Research Foundation has reported that a process called the Maillard reaction, a spontaneous reaction between sugars and proteins which leads to the formation of glycated proteins in the body, can result in the formation of amyloid plaques which are implicated in Alzheimer's disease. The firm says that this discovery should allow the development of inhibitors to the Maillard reaction, which could lead to a treatment for the disease and other neurodegenerative disorders.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight